Surrey Heartlands

Joint Formulary & PAD

Fluticasone with vilanterol (Relvar Ellipta) - Asthma

You are here : Home > Formulary Search > Fluticasone with vilanterol (Relvar Ellipta) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Inhaler (dry powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :

Documentation

Evidence Review
Relvar Ellipta in Asthma - Policy update and review -July 18
Webpage
NICE NG80 - Asthma-diagnosis-monitoring-and-chronic-asthma-management
Webpage
How to use an Ellipta inhaler - video
Patient resource
How to use an Ellipta inhaler - Patient information leaflet

PAD Profile

ChemicalSubstance :
Fluticasone with vilanterol (Relvar Ellipta)
Indication :
Asthma
Group Name :
ICS LABA
Keywords :
ICS LABAs, ICS/LABAs, inhaled corticosteroids, long-acting beta agonists, respiratory, asthmatics
Brand Names Include :
Relvar Ellipta
Important Information :

Relvar Ellipta 92/22 and 184/22 - higher dose ICS LABA for specialist recommendation only.

Once daily formulation.

Prescribe by BRAND.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Asthma
Supporting Documents :
4

Other Indications

Below are listed other indications that Fluticasone with vilanterol (Relvar Ellipta) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (0)

  • No records returned.